MDXG - MiMedx Group Inc
MiMedx Group Inc Logo

MDXG - MiMedx Group Inc

https://www.mimedx.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.

52W High
$10.14
52W Low
$5.47

MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.74
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
34.00
Forward P/E (<15 better)
19.53
EV/EBITDA (<8 favorable)
18.13
EV/Revenue (<3 favorable)
2.63
P/S (TTM) (<3 favorable)
2.90
P/B (<3 favorable)
4.88
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
1.70%
Institutions (25–75% balanced)
71.49%
Shares Outstanding
147,959,000
Float
108,772,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
363,774,000
Gross Profit (TTM)
296,303,000
EPS (TTM)
0.21
Profit Margin (>10% good)
0.09%
Operating Margin (TTM) (higher better)
0.13%
ROE (TTM) (>15% strong)
0.17%
EPS YoY (Quarterly) (>10% good)
-0.50
Revenue YoY (Quarterly) (>8% good)
0.13
Momentum
Bearish momentum
Value
0.0105
Previous
0.0300
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025